4//SEC Filing
Aralez Pharmaceuticals Inc. 4
Accession 0001104659-16-095181
CIK 0001660719operating
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 9:47 PM ET
Size
19.0 KB
Accession
0001104659-16-095181
Insider Transaction Report
Form 4
Armstrong Jennifer Lou
EVP HR and Administration
Transactions
- Other
Common Shares
2016-02-05+21,853→ 21,853 total
Footnotes (2)
- [F1]Reflects the beneficial ownership of the reporting person following consummation of the business transaction among POZEN Inc. ("Pozen"), Tribute Pharmaceuticals Canada Inc. ("Tribute") and the Registrant on February 5, 2016, pursuant to the Agreement and Plan of Merger and Arrangement as entered into on June 8, 2015 and as amended on August 19, 2015 and December 7, 2015 among Pozen, Tribute, the Registrant, Aralez Pharmaceuticals Holdings Limited, ARLZ US Acquisition II Corp., and ARLZ CA Acquisition Corp. (the "Merger").
- [F2]Represents 21,853 shares issuable pursuant to Restricted Stock Units previously granted by Pozen, predecessor to the Registrant.
Documents
Issuer
Aralez Pharmaceuticals Inc.
CIK 0001660719
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001660719
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 9:47 PM ET
- Size
- 19.0 KB